Author:
Liu Caigang,Zhang Hao,Shuang Chen,Lu Yang,Jin Feng,Xu Huimian,Lu Ping
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference30 articles.
1. Anim JT, John B, Abdulsathar SS, Prasad A, Saji T, Akhtar N, et al. Relationship between the expression of various markers and prognostic factors in breast cancer. Acta Histochem. 2005;107(2):87–93.
2. Kasami M, Uematsu T, Honda M, Yabuzaki T, Sanuki J, Uchida Y, et al. Comparison of estrogen receptor, progesterone receptor and Her-2 status in breast cancer pre- and post-neoadjuvant chemotherapy. Breast. 2008;17:523–7.
3. Kurebayashi J, Otsuki T, Kunisue H, Tanaka K, Yamamoto S, Sonoo H. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer. Clin Cancer Res. 2000;6:512e8.
4. Rody A, Diallo R, Poremba C, Speich C, Wuelfing P, Kissler S, et al. Estrogen receptor alpha and beta, progesterone receptor, pS2 and HER-2/neu expression delineate different subgroups in ductal carcinoma in situ of the breast. Oncol Rep. 2004;12:695–9.
5. Hussein MR, Abd-Elwahed SR, Abdulwahed AR. Alterations of estrogen receptors progesterone receptors, and c-erbB2 oncogene protein expression in ductal carcinomas of the breast. Cell Biol Int. 2008;32:698–707.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献